CAD and Guillain-Barre syndrome: Clinical observational studies have identified an inverse association between the level of GBS serotype-specific anti-CPS IgG antibodies in maternal sera and the risk of GBS invasive disease in neonates, suggesting that GBS vaccination of pregnant women can be a valuable strategy to protect their infants (7).